The role of plasma inflammatory markers in late-life depression and conversion to dementia: a 3-year follow-up study
Open Access
- 8 February 2025
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (7) , 3029-3038
Abstract
Late-life depression (LLD) has been linked to increased likelihood of dementia, although mechanisms responsible for this association remain largely unknown. One feature frequently observed in both LLD and dementia is elevated levels of plasma inflammatory markers. The present study aimed to compare the levels of 12 plasma inflammatory markers between older people with LLD and controls, and to explore whether these markers, along with clinical characteristics, can predict dementia in patients with LLD within 3 years of follow-up. Using multiple linear regression with stepwise adjustment, we compared levels of plasma inflammatory markers (IL-1β, IL-1ra, IL-6, IL-10, IL-17a, IL-18, IL-33, TNFα, CD40L, IFN-γ, CCL-2 and CCL-4) between 136 inpatients with LLD (PRODE cohort) and 103 cognitively healthy non-depressed controls (COGNORM cohort). In the PRODE cohort, follow-up data was available for 139 patients (of them 123 had data on baseline plasma inflammatory markers); 36 (25.9%) developed dementia by Year 3 (n = 31 for those with cytokine data). Using Cox proportional hazards regression, we explored whether inflammatory markers and clinical characteristics of LLD (age of onset, treatment response, number of episodes) predicted progression to dementia during follow-up. Levels of IL-1ra, CCL-2, CCL-4, IFN-γ and IL-17a were significantly higher in LLD patients compared to controls in the majority of models. However, none of the inflammatory markers predicted progression from LLD to dementia in the PRODE cohort. Among clinical features, only poor response to treatment significantly predicted higher risk of progression to dementia.Keywords
All Related Versions
This publication has 65 references indexed in Scilit:
- Global prevalence of depression in older adults: A systematic review and meta-analysis of epidemiological surveysAsian Journal of Psychiatry, 2022
- Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammationDiabetologia, 2020
- Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controlsBrain, Behavior, and Immunity, 2020
- Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's DiseaseMovement Disorders, 2020
- Plasma and cerebrospinal fluid inflammatory cytokines in perinatal depressionAmerican Journal of Obstetrics and Gynecology, 2019
- Absence of CCL2 is sufficient to restore hippocampal neurogenesis following cranial irradiationBrain, Behavior, and Immunity, 2013
- Midlife vs Late-Life Depressive Symptoms and Risk of DementiaArchives of General Psychiatry, 2012
- Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey InitiativeDepression and Anxiety, 2009
- Interleukin-1 Receptor Antagonist and Incident Depressive Symptoms Over 6 Years in Older Persons: The InCHIANTI StudyBiological Psychiatry, 2009
- “Mini-mental state”Journal of Psychiatric Research, 1975